OMEICOS Therapeutics GmbH Employee Directory

Biotechnology ResearchBerlin, Germany2-10 Employees

OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. 
OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease.

Find OMEICOS Therapeutics GmbH employees' phone numbers or email addresses

OMEICOS Therapeutics GmbH Global Highlights

Europe
15

Germany
13
Switzerland
2

OMEICOS Therapeutics GmbH's Leadership

R. F.
Chief Executive Officer
Mobile Phone
Email
S. R.
Chief Business Officer
Mobile Phone
Email
K. U.
Vice President Operations & Ip
Mobile Phone
Email
A. K.
Head Technology & External Research And Development
Mobile Phone
Email
J. L.
Clinical Project Manager
Mobile Phone
Email
H. J. S.
Drug Safety Officer
Mobile Phone
Email
D. F. M. L.
R&d Scientist
Mobile Phone
Email

Contact profiles from OMEICOS Therapeutics GmbH

Name

Title

Contact Info

Location

Last Update

S. R.
Chief Business Officer
Mobile Phone
Email
Switzerland
Mar 28, 2025
R. F.
Chief Executive Officer
Mobile Phone
Email
GermanyBerlin
Apr 08, 2025
K. U.
Vice President Operations & Ip
Mobile Phone
Email
GermanyBerlin
May 15, 2024
A. K.
Head Technology & External Research And Development
Mobile Phone
Email
GermanyBerlin
Mar 07, 2025
J. L.
Clinical Project Manager
Mobile Phone
Email
GermanyBerlin
Sep 26, 2024
H. J. S.
Drug Safety Officer
Mobile Phone
Email
SwitzerlandSolothurn
Apr 10, 2025
D. F. M. L.
R&d Scientist
Mobile Phone
Email
GermanyBerlin
Apr 11, 2025

Frequently Asked Questions

What is OMEICOS Therapeutics GmbH known for?

OMEICOS Therapeutics GmbH was founded in 2013 operates in the Biotechnology Research industry. The company's main headquarters is located in Robert-Roessle-Strasse 10 Berlin, 13125 DE; you can contact the main corporate office by phone at

+49-30-9489****

. Explore OMEICOS Therapeutics GmbH's company overview page for more information.

What is OMEICOS Therapeutics GmbH's most common email format?

OMEICOS Therapeutics GmbH employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more OMEICOS Therapeutics GmbH email formats with LeadIQ.

How many employees does OMEICOS Therapeutics GmbH have currently?

OMEICOS Therapeutics GmbH has approximately 9 employees as of December 2024. These team members are located across 1 continents, including Europe.

Who are OMEICOS Therapeutics GmbH's key employees and leadership?

As of December 2024, OMEICOS Therapeutics GmbH's key employees include:

Chief Executive Officer: R. F.
Chief Business Officer: S. R.
Vice President Operations & Ip: K. U.
Head Technology & External Research And Development: A. K.
Clinical Project Manager: J. L.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking